Vacuolating encephalitis in mice infected by human coronavirus OC43

Virology

Volumn 315, Issue 1, 2003, Pages 20-33

  Jacomy, Hélène ^a   Talbot, Pierre J ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Coronavirus; Encephalitis; Inflammation; Neurodegenerative disease; Spongiform like degeneration; Viral meningoencephalomyelitis

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SPONGIOSIS; CELL ACTIVITY; CELL VACUOLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORONAVIRUS; ENCEPHALITIS; EXPERIMENTATION; FEMALE; IMMUNOLOGY; IN VIVO STUDY; INFECTION; MICROGLIA; MOUSE; MOUSE STRAIN; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; VIRUS INFECTION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALIA; CORONAVIRUS; MURINAE;

EID: 0242363107     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00323-4     Document Type: Article

References (79)

1. Agapitos E., Pavlopoulos P.M., Patsouris E., Davaris P. Subacute necrotizing encephalopathy (Leigh's disease) a clinicopathologic study of ten cases . Gen. Diag. Pathol. 142:1997;341-355.
2. Allen I.V., McQuaid S., McMahon J., Kirk J., McConnell R. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J. Neuropathol. Exp. Neurol. 55:1996;471-480.
3. Arbour N., Côté G., Lachance C., Tardieu M., Cashman N.R., Talbot P.J. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J. Virol. 73:1999;3338-3350.
4. Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by human respiratory coronaviruses and association with multiple sclerosis. J. Virol. 74:2000;8913-8921.
5. Arbour N., Ekandé S., Côté G., Lachance C., Chagnon F., Tardieu M., Cashman N.R., Talbot P.J. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J. Virol. 73:1999;3326-3337.
6. Bailey O.T., Pappenheimer A.M., Cheever F.S., Daniels J. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. II. Pathology. J. Exp. Med. 90:1949;195-212.
7. Barthold S.W., Smith A.L. Mouse hepatitis virus S in weanling Swiss mice following intranasal inoculation. Lab. Anim. Sci. 33:1983;355-360.
8. Barthold S.W., Smith A.L. Response of genetically susceptible and resistance mice to intranasal inoculation with mouse hepatitis virus JHM. Virus Res. 7:1987;225-239.
9. Barthold S.W., de Souza M.S., Smith A.L. Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species. Lab. Anim. Sci. 40:1990;481-485.
10. Boland J., Atkinson K., Britton K., Darveniza P., Johnson S., Biggs J. Tissue distribution and toxicity of cyclosporin A in the mouse. Pathology. 16:1984;117-123.
11. Bolton C., Allsopp G., Cuzner M.L. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Clin. Exp. Immunol. 47:1982;127-132.
12. Bonavia A., Arbour N., Wee Yong V., Talbot P.J. Infection of primary cultures of human neural cells by human coronavirus 229E and OC43. J. Virol. 71:1997;800-806.
13. Borel J.F., Feurer C., Gubler H.U., Stahelin H. Biological effects of Cyclosporin A a new antilymphocytic agent . Agents Actions. 6:1976;468-475.
14. Boucher A., Denis F., Duquette P., Talbot P.J. Generation from multiple sclerosis patients of long-term T-cell clones that are activated by both human coronavirus and myelin antigens. Adv. Exp. Med. Biol. 494:2001;355-362.
15. Budka H., Aguzzi A., Brown P., Brucher J.M., Bugiani O., Gullotta F., Haltia M., Hauw J.J., Ironside J.W., Jellinger K., et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 5:1995;459-466.
16. Burks J.S., DeVald B.L., Jankovsky L.D., Gerdes J.C. Two coronaviruses isolated from central nervous system tissue of multiple sclerosis patients. Science. 209:1980;933-934.
17. Calne D.B., Eisen A., McGeer E., Spencer P. Alzheimer's disease, Parkinson's disease, and motoneuron disease abiotrophic interaction between ageing and environment . Lancet. 8:1986;1067-1070.
18. Czub S., Lynch W.P., Czub M., Portis J.L. Kinetic analysis of spongiform neurodegenerative disease induced by a highly virulent murine retrovirus. Lab. Invest. 70:1994;711-723.
19. Deruaz J.P., Assal G., Peter-Favre C. A clinicopathological case of progressive aphasia. Rev. Neurol. (Paris). 149:1993;186-191.
20. Duffy P., Mayeux R., Kupsky W. Familial Alzheimer's disease with myoclonus and "spongy change" Arch. Neurol. 45:1988;1097-1100.
21. Elliott J.F., Lin Y., Mizel S.B., Bleackley R.C., Harnish D.G., Paetkau V. Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science. 226:1984;1439-1441.
22. Fishman P.S., Gass J.S., Swoveland P.T., Lavi E., Highkin M.K., Weiss S.R. Infection of the basal ganglia by a murine coronavirus. Science. 30:1985;877-879.
23. Gardner M.B., Henderson B.E., Officer J.E., Rongey R.W., Parker J.C., Oliver C., Estes J.D., Huebner R.J. A spontaneous lower motor neuron disease apparently caused by endogenous type-C RNA virus in wild mice. J. Natl. Cancer Int. 51:1973;1243-1254.
24. Georgsson G. Neuropathologic aspects of lentiviral infections. Ann. NY Acad. Sci. 6:1994;50-67.
25. Giraud P., Beaulieux F., Ono S., Shimizu N., Chazot G., Lina B. Detection of enteroviral sequences from frozen spinal cord samples of Japanese ALS patients. Neurology. 26:2001;1777-1778.
26. Goldwater P.N., Paton J.C. Apparent non-involvement of prions in the pathogenesis of spongiform change in HIV-infected brain. J. Neuropathol. Exp. Neurol. 48:1989;184-186.
27. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin a specific cytosolic binding protein for cyclosporin A . Science. 226:1984;544-547.
28. Hayase Y., Tobita K. Influenza virus and neurological diseases. Psychiatry Clin. Neurosci. 51:1997;181-184.
29. Jacomy H., Bosler O. Intrinsic organization and monoaminergic innervation of the suprachiasmatic nucleus transplanted to adult rats. A light- and electronic- microscopic study. J. Neurocytol. 25:1996;659-673.
30. Jacomy H., Talbot P.J. Susceptibility of murine CNS to OC43 infection. Adv. Exp. Med. Biol. 494:2001;101-107.
31. Jacomy H., Zhu Q., Couillard-Despres S., Beaulieu J.M., Julien J.P. Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits. J. Neurochem. 73:1999;972-984.
32. Jubelt B., Berger J.R. Does viral disease underlie ALS? Lessons from the AIDS pandemic. Neurology. 57:2001;945-946.
33. Kimura S., Kobayashi T., Amemiya F. Myelin splitting in the spongy lesion in Leigh encephalopathy. Pediatr. Neurol. 7:1991;56-58.
34. King L.E., Morford L.A., Gibbons J.P., Fraker P.J. Flow cytometric analysis of the expression of murine B and T surface markers from the birth to adulthood. Immunol. Lett. 31:1992;73-78.
35. Kirk J., Zhou A.L. Viral infection at the blood-brain barrier in multiple sclerosis an ultrastructural study of tissues from a UK Regional Brain Bank . Mult. Scler. 1:1996;242-252.
36. Klein R., Mullges W., Bendszus M., Woydt M., Kreipe H., Roggendorf W. Primary intracerebral Hodgkin's disease report of a case with Epstein-Barr virus association and review of the literature . Am. J. Surg. Pathol. 23:1999;477-481.
37. Koskiniemi M., Vaheri A. Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet. 7:1989;31-34.
38. Kristensson K., Holmes K.V., Duchala C.S., Zeller N.K., Lazzarini R.A., Dubois-Dalcq M. Increased levels of myelin basic protein transcripts in virus-induced demyelination. Nature. 322:1986;544-547.
39. Kristensson K. Potential role of viruses in neurodegeneration. Mol. Chem. Neuropathol. 16:1992;45-58.
40. Kupiec-Weglinski J.W., Filho M.A., Strom T.B., Tilney N.L. Sparing of suppressor cells a critical action of cyclosporine . Transplantation. 38:1984;97-101.
41. Lampert P.W., Sims J.K., Kniazeff A.J. Mechanism of demyelination in JHM virus encephalomyelitis. Acta Neuropathol. 24:1973;76-85.
42. Lavi E., Gilden D.H., Wroblewska Z., Rorke L.B., Weiss S.R. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology. 34:1984;597-603.
43. Lavi E., Gilden D.H., Highkin M.K., Weiss S.R. The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab. Anim. Sci. 36:1986;130-135.
44. Lavi E., Fishman P.S., Highkin M.K., Weiss S.R. Limbic encephalitis after inhalation of a murine coronavirus. Lab. Invest. 58:1988;31-36.
45. Lewis D.A. Retroviruses and pathogenesis of schizophrenia. Proc. Natl. Acad. Sci. USA. 98:2001;4293-4294.
46. McIntosh K. Fields B.N., Knipe D.M., et al. Virology. third ed:1996;1095-1103 Raven Press, New York.
47. McKelvie P.A., Morley J.B., Byrne E., Marzuki S. Mitochondrial encephalomyopathies a correlation between neuropathological findings and defects in mitochondrial DNA . J. Neurol. Sci. 102:1991;51-60.
48. Mounir S., Talbot P.J. Sequence analysis of the membrane protein gene of human coronavirus OC43 and evidence for O-glycosylation. J. Gen. Virol. 73:1992;2731-2736.
49. Murray R.S., Brown B., Brian D., Cabirac G.F. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann. Neurol. 31:1992;525-533.
50. Myint S.H. Human coronavirus - a brief review. Rev. Med. Virol. 4:1994;35-46.
51. Pasick J.M., Wilson G.A., Morris V.L., Dales S. SJL/J resistance to mouse hepatitis virus-JHM-induced neurologic disease can be partially overcome by viral variants of S and host immunosuppression. Microb. Pathog. 13:1992;1-15.
52. Pearson J., Mims C.A. Selective vulnerability of neural cells and age-related susceptibility to OC43 virus in mice. Arch. Virol. 77:1983;109-118.
53. Penn I. Cancers following cyclosporine therapy. Transplantation. 43:1987;32-35.
54. Perlman S., Ries D. The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb. Pathog. 3:1987;309-1449.
55. Perlman S. Pathogenesis of coronavirus-induced infections. Review of pathological and immunological aspects. Adv. Exp. Med. Biol. 440:1998;503-513.
56. Perlman S., Evans G., Afifi A. Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. J. Exp. Med. 172:1990;1127-1132.
57. Perlman S., Jacobsen G., Olson A.L., Afifi A. Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus. Virology. 175:1990;418-426.
58. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. USA. 95:1998;13363-13383.
59. Rabinowitz S.G., Dal Canto M.C., Johnson T.C. Comparison of central nervous system disease produced by wild-type and temperature-sensitive mutants of vesicular stomatis virus. Infect. Immunol. 13:1976;1242-1249.
60. Resta S., Luby J.P., Rosenfeld C.R., Siegel J.D. Isolation and propagation of a human enteric coronavirus. Science. 229:1985;978-981.
61. Rhodes R.H. Histopathology of the central nervous system in the acquired immunodeficiency syndrome. Hum. Pathol. 18:1987;636-643.
62. Riski N., Hovi T. Coronavirus infections of man associated with diseases other than the common cold. J. Med. Virol. 6:1980;259-265.
63. Rupprecht C.E., Hanlon C.A., Hemachudha T. Rabies re-examined. Lancet Infect. Dis. 2:2002;327-343.
64. Shevach E.M. The effects of cyclosporin A on the immune system. Annu. Rev. Immunol. 3:1985;397-423.
65. Shoji H., Azuma K., Nishimura Y., Fujimoto H., Sugita Y., Eizuru Y. Acute viral encephalitis the recent progress . Intern. Med. 41:2002;420-428.
66. Sizun J., Yu M.W., Talbot P.J. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces a possible source of hospital-acquired infections . J. Hosp. Infect. 46:2000;55-60.
67. Sola P., Bedin R., Casoni F., Barrozzi P., Mandrioli J., Merelli E. New insights into the viral theory of amyotrophic lateral sclerosis study on the possible role of Kaposi's sarcoma-associated virus/human herpesvirus 8 . Eur. Neurol. 47:2002;108-112.
68. Stewart J.N., Mounir S., Talbot P.J. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology. 191:1992;502-505.
69. Sun N., Grzybicki D.M., Castro R.F., Murphy S.P., Perlman S. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology. 213:1995;482-493.
70. Sun N., Perlman S. Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J. Virol. 69:1995;633-641.
71. Sussman M.A., Shubin R.A., Kyuwa S., Stohlman S.A. T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J. Virol. 63:1989;3051-3056.
72. Talbot P.J., Knobler R.L., Buchmeier M.J. Western and dot immunoblotting analysis of viral antigens and antibodies application to murine hepatitis virus . J. Immunol. Methods. 73:1984;177-188.
73. Walther M., Kuklinski S., Pesheva P., Guntinas-Lichius O., Angelov D.N., Neiss W.F., Asou H., Probstmeier R. Galectin-3 is upregulated in microglial cells in response to ischemic brain lesions, but not to facial nerve axotomy. J. Neurosci. Res. 15:2000;430-435.
74. Waltrip R.W. 2nd., Buschanan R.W., Summerfelt A., Breier A., Carpenter W.T., Bryant N.L., Rubin S.A., Carbone K.M. Borna disease virus and schizophrenia. Psychiatry Res. 56:1995;33-44.
75. Wang F.I., Stohlman S.A., Fleming J.O. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J. Neuroimmunol. 30:1990;31-34.
76. Weiner L.P. Pathogenesis of demyelination induced by mouse hepatitis virus. Arch. Neurol. 28:1973;298-303.
77. Whitley R.J., Gnann J.W. Viral encephalitis familiar infections and emerging pathogens . Lancet. 359:2002;507-513.
78. Woyciechowska J.L., Trapp B.D., Patrick D.H., Shekarchi I.C., Leinikki P.O., Sever J.L., Holmes K.V. Acute and subacute demyelination induced by mouse hepatitis virus strain A59 in C3H mice. J. Exp. Pathol. 1:1984;295-306.
79. Zimmer M.J., Dales S. In vivo and in vitro models of demyelinating diseases XXIV. The infectious process in cyclosporin A treated Winstar Lewis rats inoculated with JHM virus. Microbial Pathog. 6:1989;7-16.